Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference

Research output: Contribution to journalReview article

Standard

Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference. / Wahren, Britta; Biswas, Priscilla; Borggren, Marie; Coleman, Adam; Da Costa, Kelly; De Haes, Winni; Dieltjens, Tessa; Dispinseri, Stefania; Grupping, Katrijn; Hallengard, David; Hornig, Julia; Klein, Katja; Mainetti, Lara; Palma, Paolo; Reudelsterz, Marc; Seifried, Janna; Selhorst, Philippe; Skold, Annette; van Gils, Marit J.; Weber, Caroline; Shattock, Robin; Scarlatti, Gabriella.

In: Journal of Translational Medicine, Vol. 8, 2010.

Research output: Contribution to journalReview article

Harvard

Wahren, B, Biswas, P, Borggren, M, Coleman, A, Da Costa, K, De Haes, W, Dieltjens, T, Dispinseri, S, Grupping, K, Hallengard, D, Hornig, J, Klein, K, Mainetti, L, Palma, P, Reudelsterz, M, Seifried, J, Selhorst, P, Skold, A, van Gils, MJ, Weber, C, Shattock, R & Scarlatti, G 2010, 'Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference', Journal of Translational Medicine, vol. 8. https://doi.org/10.1186/1479-5876-8-72

APA

Wahren, B., Biswas, P., Borggren, M., Coleman, A., Da Costa, K., De Haes, W., ... Scarlatti, G. (2010). Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference. Journal of Translational Medicine, 8. https://doi.org/10.1186/1479-5876-8-72

CBE

Wahren B, Biswas P, Borggren M, Coleman A, Da Costa K, De Haes W, Dieltjens T, Dispinseri S, Grupping K, Hallengard D, Hornig J, Klein K, Mainetti L, Palma P, Reudelsterz M, Seifried J, Selhorst P, Skold A, van Gils MJ, Weber C, Shattock R, Scarlatti G. 2010. Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference. Journal of Translational Medicine. 8. https://doi.org/10.1186/1479-5876-8-72

MLA

Vancouver

Author

Wahren, Britta ; Biswas, Priscilla ; Borggren, Marie ; Coleman, Adam ; Da Costa, Kelly ; De Haes, Winni ; Dieltjens, Tessa ; Dispinseri, Stefania ; Grupping, Katrijn ; Hallengard, David ; Hornig, Julia ; Klein, Katja ; Mainetti, Lara ; Palma, Paolo ; Reudelsterz, Marc ; Seifried, Janna ; Selhorst, Philippe ; Skold, Annette ; van Gils, Marit J. ; Weber, Caroline ; Shattock, Robin ; Scarlatti, Gabriella. / Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference. In: Journal of Translational Medicine. 2010 ; Vol. 8.

RIS

TY - JOUR

T1 - Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference

AU - Wahren, Britta

AU - Biswas, Priscilla

AU - Borggren, Marie

AU - Coleman, Adam

AU - Da Costa, Kelly

AU - De Haes, Winni

AU - Dieltjens, Tessa

AU - Dispinseri, Stefania

AU - Grupping, Katrijn

AU - Hallengard, David

AU - Hornig, Julia

AU - Klein, Katja

AU - Mainetti, Lara

AU - Palma, Paolo

AU - Reudelsterz, Marc

AU - Seifried, Janna

AU - Selhorst, Philippe

AU - Skold, Annette

AU - van Gils, Marit J.

AU - Weber, Caroline

AU - Shattock, Robin

AU - Scarlatti, Gabriella

PY - 2010

Y1 - 2010

N2 - EUROPRISE is a Network of Excellence sponsored from 2007 to 2011 by the European Commission within the 6th Framework Program. The Network encompasses a wide portfolio of activities ranging from an integrated research program in the field of HIV vaccines and microbicides to training, dissemination and advocacy. The research program covers the whole pipeline of vaccine and microbicide development from discovery to early clinical trials. The Network is composed of 58 partners representing more than 65 institutions from 13 European countries; it also includes three major pharmaceutical companies (GlaxoSmithKline, Novartis and Sanofi-Pasteur) involved in HIV microbicide and vaccine research. The Network displays a dedicated and informative web page: http://www.europrise.org. Finally, a distinguishing trait of EUROPRISE is its PhD School of students from across Europe, a unique example in the world of science aimed at spreading excellence through training. EUROPRISE held its second annual conference in Budapest in November, 2009. The conference had 143 participants and their presentations covered aspects of vaccine and microbicide research, development and discovery. Since training is a major task of the Network, the students of the EUROPRISE PhD program summarized certain presentations and their view of the conference in this paper.

AB - EUROPRISE is a Network of Excellence sponsored from 2007 to 2011 by the European Commission within the 6th Framework Program. The Network encompasses a wide portfolio of activities ranging from an integrated research program in the field of HIV vaccines and microbicides to training, dissemination and advocacy. The research program covers the whole pipeline of vaccine and microbicide development from discovery to early clinical trials. The Network is composed of 58 partners representing more than 65 institutions from 13 European countries; it also includes three major pharmaceutical companies (GlaxoSmithKline, Novartis and Sanofi-Pasteur) involved in HIV microbicide and vaccine research. The Network displays a dedicated and informative web page: http://www.europrise.org. Finally, a distinguishing trait of EUROPRISE is its PhD School of students from across Europe, a unique example in the world of science aimed at spreading excellence through training. EUROPRISE held its second annual conference in Budapest in November, 2009. The conference had 143 participants and their presentations covered aspects of vaccine and microbicide research, development and discovery. Since training is a major task of the Network, the students of the EUROPRISE PhD program summarized certain presentations and their view of the conference in this paper.

U2 - 10.1186/1479-5876-8-72

DO - 10.1186/1479-5876-8-72

M3 - Review article

VL - 8

JO - Journal of Translational Medicine

T2 - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

ER -